Results 31 to 40 of about 46,152 (260)

Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against Candida glabrata

open access: yesJournal of Fungi, 2022
In vitro interactions of broad-spectrum azole isavuconazole with flavonoid isoquercitrin were evaluated by a broth microdilution checkerboard technique based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methodology
Petra V. Schwarz   +5 more
doaj   +1 more source

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study [PDF]

open access: yes, 2013
Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units in Spain and Germany ...
Ballus, Jose   +7 more
core   +1 more source

SPREAD OF ESPECIALLY DANGEROUS MYCOSES IN THE WORLD

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2016
Contemporary information on the spread in the world of especially dangerous mycoses - coccidioidomycosis, histoplasmosis, blastomycosis and paracoccidioidomycosis are presented in the review.
A. Yu. Popova   +4 more
doaj   +1 more source

Multilocus sequence typing of azole-resistant Candida auris strains, South Africa

open access: yesSouthern African Journal of Infectious Diseases, 2020
Background: Candida auris is an emerging multidrug-resistant fungal pathogen associated with high mortality. Methods: We investigated the genetic relatedness of clinical C.
Rindidzani Magobo   +3 more
doaj   +1 more source

Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update

open access: yesSouth African Medical Journal, 2022
Background. The emergence of carbapenem-resistant Enterobacterales (CRE) has become a serious and significant public health threat worldwide, owing to the limited antimicrobial therapy options, and the elevated mortality rates associated with ...
M Lowe, L Shuping, O Perovic
doaj   +1 more source

AIDS-Related Mycoses: Current Progress in the Field and Future Priorities. [PDF]

open access: yes, 2017
Opportunistic fungal infections continue to take an unacceptably heavy toll on the most disadvantaged living with HIV-AIDS, and are a major driver for HIV-related deaths. At the second EMBO Workshop on AIDS-Related Mycoses, clinicians and scientists from
Armstrong-James, D   +6 more
core   +2 more sources

Mycotic infections in rheumatology

open access: yesСовременная ревматология, 2017
Invasive mycoses are becoming a more relevant problem in modern rheumatology. There are difficulties in the lifetime diagnosis and treatment of mycoses in patients with rheumatic diseases.
B. S. Belov   +2 more
doaj   +1 more source

A randomized controlled trial evaluating the efficacy and safety of a MYCOFUNGI CREAM in patients with skin mycoses

open access: yesJournal of Pre-Clinical and Clinical Research, 2022
Introduction and objective Skin mycoses is a neglected condition with low quality of life and morbidity that primarily affects school-aged children in developing nations.
Roger Ducos Youmsi Fokouo   +9 more
doaj   +1 more source

Identification of yeasts present in artisanal yoghurt and traditionally fermented milks consumed in the northern part of Cameroon [PDF]

open access: yes, 2019
Bacteria generally ferment milk but, sometimes, yeasts are found in fermented milks. The presence of these yeasts in the microbial community of some fermented milks could be intentional or accidental.
Maïworé, Justine   +3 more
core   +1 more source

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. [PDF]

open access: yes, 2017
Purpose of reviewDiagnosis during early stages of invasive aspergillosis (IA) and targeted antifungal treatment has the potential to improve survival significantly.
Heldt, Sven, Hoenigl, Martin
core   +1 more source

Home - About - Disclaimer - Privacy